Skip to content

Clinical trials

Gastrointestinal Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Country / region: Norway Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20131
20141
20201
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting1
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Pfizer2
Anthos Therapeutics, Inc.1
Isofol Medical AB1
Sykehuset Telemark1
Ullevaal University Hospital1
University Hospital, Akershus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms9
Colorectal Neoplasms3
Gastrointestinal Diseases3
Intestinal Neoplasms2
Rectal Diseases2
Rectal Neoplasms2
Biliary Tract Neoplasms1
Colonic Diseases1
Colonic Neoplasms1
Digestive System Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.